Kentucky Statutes 311.7734 – Requirements for physician providing abortion-inducing drug — Examination and follow-up visit
Current as of: 2024 | Check for updates
|
Other versions
(1) A qualified physician providing an abortion-inducing drug as defined in KRS
311.7731 shall:
(a) Be credentialed and competent to handle complication management, including emergency transfer; or
(b) Have a signed contract with an associated physician who is credentialed to handle complications and produce that signed contract, including the name and phone number of the associated physician, upon the request of the cabinet and each pregnant patient.
(2) A qualified physician providing an abortion-inducing drug as defined in KRS
311.7731 shall examine the patient in person and, prior to providing an abortion-inducing drug, shall:
(a) Independently verify that a pregnancy exists;
(b) Determine the patient’s blood type and, if the patient is Rh negative, provide the patient with an Rh negative information fact sheet and offer to provide treatment with the prevailing medical standard of care to prevent harmful fetal or child outcomes or Rh incompatibility in future pregnancies at the time of the abortion;
(c) Inform the patient that the remains of the unborn child may be visible in the process of completing the abortion; and
(d) Document, in the patient’s medical chart, the gestational age and intrauterine location of the pregnancy, and whether the patient received treatment for Rh negativity, as diagnosed, by the most accurate standard of medical care.
(3) (a) The qualified physician or an agent of the qualified physician providing any abortion-inducing drug as defined in KRS § 311.7731 shall schedule a follow-up visit for the patient for approximately seven (7) to fourteen (14) days after administration of the abortion-inducing drug to confirm that the pregnancy is completely terminated and to assess any degree of bleeding.
(b) The qualified physician shall make all reasonable efforts to ensure that the patient returns for the scheduled appointment.
(c) A brief description of the efforts made to comply with this subsection, including the date, time, and identification by name of the person making such efforts, shall be included in the patient’s medical record.
Effective:April 14, 2022
History: Created 2022 Ky. Acts ch. 210, sec. 7, effective April 14, 2022.
311.7731 shall:
Terms Used In Kentucky Statutes 311.7734
- Contract: A legal written agreement that becomes binding when signed.
- Treatment: when used in a criminal justice context, means targeted interventions
that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010
(a) Be credentialed and competent to handle complication management, including emergency transfer; or
(b) Have a signed contract with an associated physician who is credentialed to handle complications and produce that signed contract, including the name and phone number of the associated physician, upon the request of the cabinet and each pregnant patient.
(2) A qualified physician providing an abortion-inducing drug as defined in KRS
311.7731 shall examine the patient in person and, prior to providing an abortion-inducing drug, shall:
(a) Independently verify that a pregnancy exists;
(b) Determine the patient’s blood type and, if the patient is Rh negative, provide the patient with an Rh negative information fact sheet and offer to provide treatment with the prevailing medical standard of care to prevent harmful fetal or child outcomes or Rh incompatibility in future pregnancies at the time of the abortion;
(c) Inform the patient that the remains of the unborn child may be visible in the process of completing the abortion; and
(d) Document, in the patient’s medical chart, the gestational age and intrauterine location of the pregnancy, and whether the patient received treatment for Rh negativity, as diagnosed, by the most accurate standard of medical care.
(3) (a) The qualified physician or an agent of the qualified physician providing any abortion-inducing drug as defined in KRS § 311.7731 shall schedule a follow-up visit for the patient for approximately seven (7) to fourteen (14) days after administration of the abortion-inducing drug to confirm that the pregnancy is completely terminated and to assess any degree of bleeding.
(b) The qualified physician shall make all reasonable efforts to ensure that the patient returns for the scheduled appointment.
(c) A brief description of the efforts made to comply with this subsection, including the date, time, and identification by name of the person making such efforts, shall be included in the patient’s medical record.
Effective:April 14, 2022
History: Created 2022 Ky. Acts ch. 210, sec. 7, effective April 14, 2022.